NOTCH1 and neoplasm: Inhibition of Notch1 leads to hypersprouting and vessel dysfunction, increased hypoxia, and ultimately decreased tumor growth, but candidate therapeutics targeting Notch1 have exhibited significant toxicity in normal tissue (31, 32).